Results 161 to 170 of about 7,371 (204)

Negative association between serum calcium and glucocorticoid-induced hypertension in thyroid-associated ophthalmopathy patients treated with methylprednisolone. [PDF]

Front Endocrinol (Lausanne)
Wang L, Sun Y, Zhang M, He H, Wang J, Xu H, Hao Y, Zhang W, Wang Y, Chong KKL, Guo H, Shi B, Wang Y.   +12 more
europepmc   +1 more source

White matter structural changes in the visual pathway of thyroid-associated ophthalmopathy patients: a free water and multi-shell diffusion imaging study. [PDF]

Front Neurol
Yao J, Lu X, Ma J, Hao L, Liu Y, Huang X, Liu J, Tong B.   +7 more
europepmc   +1 more source

Progress in thyroid-associated ophthalmopathy.

Autoimmunity, 1997
J, Wall, J S, Kennerdell
openaire   +1 more source

Signatures of Six Autophagy-Related Genes as Diagnostic Markers of Thyroid-Associated Ophthalmopathy and Their Correlation With Immune Infiltration. [PDF]

Immun Inflamm Dis
Ma Q, Hai Y, Shen J.
europepmc   +1 more source

The CD163 + tissue-infiltrating macrophages regulate ferroptosis in thyroid-associated ophthalmopathy orbital fibroblasts via the TGF-β/Smad2/3 signaling pathway. [PDF]

J Transl Med
Li X, Wang S, Cao H, Xu S, Xiong C, Yu J, Chen Y, Ren Z, Li M, Hu Y, Gan P, Xu Q, Wang Y, Liao H.   +13 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Radioiodine and thyroid-associated ophthalmopathy

Orbit, 1996
Particular attention has recently been paid to the relationship between radioiodine administration and the course of thyroid-associated ophthalmopathy (TAO). Conflicting results have been reported in the literature, and radioiodine therapy has been associated either with aggravation, improvement, or no relevant changes of eye disease.
Claudio Marcocci, Luigi Bartalena, Fausto Bogazzi   +2 more
exaly   +2 more sources

Rituximab for thyroid-associated ophthalmopathy

Cochrane Database of Systematic Reviews, 2022
Thyroid-associated ophthalmopathy (TAO) is the most frequent extrathyroidal manifestation of Graves' disease, affecting up to 50% of patients. It has a great impact on quality of life. Rituximab (RTX) is a human/murine chimeric monoclonal antibody that targets the CD20 receptor on B-lymphocytes.
Swan, Kang, Shirin, Hamed Azzam, Neda, Minakaran, Daniel G, Ezra   +3 more
openaire   +4 more sources

The pathogenesis of thyroid-associated ophthalmopathy

Journal of Endocrinology, 1989
TAO is an autoimmune disease the pathogenesis of which is unclear. Autoimmunity against orbital antigens has been demonstrated, although the precise immunological mechanisms responsible are unidentified. Cytokines probably play an important mediating role.
P, Perros, P, Kendall-Taylor
openaire   +2 more sources

Pathogenesis of thyroid-associated ophthalmopathy

Trends in Endocrinology & Metabolism, 1993
Thyroid-associated ophthalmopathy is a complex disease whose pathogenesis is thought to be autoimmune. Evidence has accumulated to implicate lymphocytes, antibodies, and cytokines targeting the orbital tissues whose structural and functional characteristics are unique.
P, Perros, P, Kendall-Taylor
openaire   +2 more sources

The pathophysiology of thyroid-associated ophthalmopathy

Ophthalmology Clinics of North America, 2002
TAO is an inflammatory disease of the orbital tissues. The effects of inflammation, mediated through cytokine release, include proliferation of fibroblasts, increased deposition of extracellular matrix, and adipocyte differentiation and proliferation. As a result, edema, enlargement of the extraocular muscles, and increased volume of the orbital soft ...
Mark P, Hatton, Peter A D, Rubin
openaire   +2 more sources